A combined in vivo neurochemical and electrophysiological analysis of the effect of high-frequency stimulation of the subthalamic nucleus on 5-HT transmission

Experimental Neurology

Volumn 233, Issue 1, 2012, Pages 145-153

  Tan, Sonny K H ^a,b,d   Hartung, Henrike ^c   Visser Vandewalle, Veerle ^a,b   Steinbusch, Harry W M ^a,d   Temel, Yasin ^a,b,d   Sharp, Trevor ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d European Graduate School of Neuroscience   (Netherlands)

Author keywords

5 HT; Deep brain stimulation; Depression; In vivo electrophysiology; Microdialysis; Parkinson's disease; Subthalamic nucleus

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DOPAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN REGION; CONTROLLED STUDY; DENERVATION; ELECTROCHEMICAL ANALYSIS; ELECTRODE; EXTRACELLULAR SPACE; HIGH FREQUENCY STIMULATION; IN VIVO STUDY; LIMIT OF DETECTION; MALE; MEDIAL PREFRONTAL CORTEX; MESENCEPHALON; MICRODIALYSIS; NERVE CELL FIRING; NERVE CELL STIMULATION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; RAPHE NUCLEUS; RAT; REFRACTORY PERIOD; SEROTONINERGIC TRANSMISSION; SUBTHALAMIC NUCLEUS;

ACTION POTENTIALS; ADRENERGIC AGENTS; ANALYSIS OF VARIANCE; ANIMALS; BIOPHYSICS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEEP BRAIN STIMULATION; DISEASE MODELS, ANIMAL; DOPAMINE; ELECTROCHEMISTRY; EXTRACELLULAR FLUID; MALE; MICRODIALYSIS; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SUBTHALAMIC NUCLEUS; SYNAPTIC TRANSMISSION; TIME FACTORS; WAKEFULNESS;

EID: 84856231454     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.08.027     Document Type: Article

References (65)

1. Allers K.A., Sharp T. Neurochemical and anatomical identification of fast- and slow-firing neurones in the rat dorsal raphe nucleus using juxtacellular labelling methods in vivo. Neuroscience 2003, 122:193-204.
2. Appleby B.S., Duggan P.S., Regenberg A., Rabins P.V. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience. Mov. Disord. 2007, 22:1722-1728.
3. Asberg M., Thoren P., Traskman L., Bertilsson L., Ringberger V. "Serotonin depression"-a biochemical subgroup within the affective disorders?. Science 1976, 191:478-480.
4. Berney A., Vingerhoets F., Perrin A., Guex P., Villemure J.G., Burkhard P.R., Benkelfat C., Ghika J. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology 2002, 59:1427-1429.
5. 11C]DASB; comparison with bipolar disorder. Biol. Psychiatry 2007, 62:870-877.
6. Carta M., Carlsson T., Kirik D., Bjorklund A. Dopamine released from 5-HT terminals is the cause of l-DOPA-induced dyskinesia in parkinsonian rats. Brain 2007, 130:1819-1833.
7. Desbonnet L., Temel Y., Visser-Vandewalle V., Blokland A., Hornikx V., Steinbusch H.W. Premature responding following bilateral stimulation of the rat subthalamic nucleus is amplitude and frequency dependent. Brain Res. 2004, 1008:198-204.
8. Deuschl G., Schade-Brittinger C., Krack P., Volkmann J., Schafer H., Botzel K., Daniels C., Deutschlander A., Dillmann U., Eisner W., Gruber D., Hamel W., Herzog J., Hilker R., Klebe S., Kloss M., Koy J., Krause M., Kupsch A., Lorenz D., Lorenzl S., Mehdorn H.M., Moringlane J.R., Oertel W., Pinsker M.O., Reichmann H., Reuss A., Schneider G.H., Schnitzler A., Steude U., Sturm V., Timmermann L., Tronnier V., Trottenberg T., Wojtecki L., Wolf E., Poewe W., Voges J. A randomized trial of deep-brain stimulation for Parkinson's disease. N. Engl. J. Med. 2006, 355:896-908.
9. Di Chiara G. In-vivo brain dialysis of neurotransmitters. Trends Pharmacol. Sci. 1990, 11:116-121.
10. Drapier S., Raoul S., Drapier D., Leray E., Lallement F., Rivier I., Sauleau P., Lajat Y., Edan G., Verin M. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease. J. Neurol. 2005, 252:583-588.
11. Drapier D., Peron J., Leray E., Sauleau P., Biseul I., Drapier S., Le Jeune F., Travers D., Bourguignon A., Haegelen C., Millet B., Verin M. Emotion recognition impairment and apathy after subthalamic nucleus stimulation in Parkinson's disease have separate neural substrates. Neuropsychologia 2008, 46:2796-2801.
12. Eusebio A., Thevathasan W., Doyle Gaynor L., Pogosyan A., Bye E., Foltynie T., Zrinzo L., Ashkan K., Aziz T., Brown P. Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients. J. Neurol. Neurosurg. Psychiatry 2010, 82:569-573.
13. Hajos M., Gartside S.E., Villa A.E., Sharp T. Evidence for a repetitive (burst) firing pattern in a sub-population of 5-hydroxytryptamine neurons in the dorsal and median raphe nuclei of the rat. Neuroscience 1995, 69:189-197.
14. Hamani C., Diwan M., Macedo C.E., Brandao M.L., Shumake J., Gonzalez-Lima F., Raymond R., Lozano A.M., Fletcher P.J., Nobrega J.N. Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biol. Psychiatry 2010, 67:117-124.
15. Harsing L.G. The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat. Curr. Neuropharmacol. 2006, 4:313-339.
16. Hartung H., Tan S.K., Steinbusch H.M., Temel Y., Sharp T. High-frequency stimulation of the subthalamic nucleus inhibits the firing of juxtacellular labelled 5-HT-containing neurones. Neuroscience 2011, 186:135-145.
17. Heym J., Steinfels G.F., Jacobs B.L. Chloral hydrate anesthesia alters the responsiveness of central serotonergic neurons in the cat. Brain Res. 1984, 291:63-72.
18. Kalen P., Strecker R.E., Rosengren E., Bjorklund A. Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection. J. Neurochem. 1988, 51:1422-1435.
19. Krack P., Batir A., Van Blercom N., Chabardes S., Fraix V., Ardouin C., Koudsie A., Limousin P.D., Benazzouz A., LeBas J.F., Benabid A.L., Pollak P. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med. 2003, 349:1925-1934.
20. Kuhn A.A., Kempf F., Brucke C., Gaynor Doyle L., Martinez-Torres I., Pogosyan A., Trottenberg T., Kupsch A., Schneider G.H., Hariz M.I., Vandenberghe W., Nuttin B., Brown P. High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance. J. Neurosci. 2008, 28:6165-6173.
21. Kumar R., Lozano A.M., Sime E., Halket E., Lang A.E. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation. Neurology 1999, 53:561-566.
22. Lacombe E., Carcenac C., Boulet S., Feuerstein C., Bertrand A., Poupard A., Savasta M. High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats. Eur. J. Neurosci. 2007, 26:1670-1680.
23. Lehmkuhle M.J., Bhangoo S.S., Kipke D.R. The electrocorticogram signal can be modulated with deep brain stimulation of the subthalamic nucleus in the hemiparkinsonian rat. J. Neurophysiol. 2009, 102:1811-1820.
24. Li X.H., Wang J.Y., Gao G., Chang J.Y., Woodward D.J., Luo F. High-frequency stimulation of the subthalamic nucleus restores neural and behavioral functions during reaction time task in a rat model of Parkinson's disease. J. Neurosci. Res. 2010, 88:1510-1521.
25. Lyons K.E., Pahwa R. Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson disease. J. Neurosurg. 2005, 103:252-255.
26. McQuade R., Sharp T. Release of cerebral 5-hydroxytryptamine evoked by electrical stimulation of the dorsal and median raphe nuclei: effect of a neurotoxic amphetamine. Neuroscience 1995, 68:1079-1088.
27. Meyer J.H. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J. Psychiatry Neurosci. 2007, 32:86-102.
28. 18F]setoperone PET imaging study. Am. J. Psychiatry 2001, 158:78-85.
29. Meyer J.H., Houle S., Sagrati S., Carella A., Hussey D.F., Ginovart N., Goulding V., Kennedy J., Wilson A.A. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch. Gen. Psychiatry 2004, 61:1271-1279.
30. Michelsen K.A., Schmitz C., Steinbusch H.W. The dorsal raphe nucleus-from silver stainings to a role in depression. Brain Res. Rev. 2007, 55:329-342.
31. Munoz A., Li Q., Gardoni F., Marcello E., Qin C., Carlsson T., Kirik D., Di Luca M., Bjorklund A., Bezard E., Carta M. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of l-DOPA-induced dyskinesia. Brain 2008, 131:3380-3394.
32. Navailles S., Benazzouz A., Bioulac B., Gross C., De Deurwaerdere P. High-frequency stimulation of the subthalamic nucleus and l-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease. J. Neurosci. 2010, 30:2356-2364.
33. O'Hearn E., Molliver M.E. Organization of raphe-cortical projections in rat: a quantitative retrograde study. Brain Res. Bull. 1984, 13:709-726.
34. Oquendo M.A., Placidi G.P., Malone K.M., Campbell C., Keilp J., Brodsky B., Kegeles L.S., Cooper T.B., Parsey R.V., van Heertum R.L., Mann J.J. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch. Gen. Psychiatry 2003, 60:14-22.
35. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego.
36. Peyron C., Petit J.M., Rampon C., Jouvet M., Luppi P.H. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience 1998, 82:443-468.
37. Samii A., Kelly V.E., Slimp J.C., Shumway-Cook A., Goodkin R. Staged unilateral versus bilateral subthalamic nucleus stimulator implantation in Parkinson disease. Mov. Disord. 2007, 22:1476-1481.
38. Schrag A., Jahanshahi M., Quinn N. What contributes to quality of life in patients with Parkinson's disease?. J. Neurol. Neurosurg. Psychiatry 2000, 69:308-312.
39. Sharp T., Bramwell S.R., Clark D., Grahame-Smith D.G. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurochem. 1989, 53:234-240.
40. Shen K.Z., Zhu Z.T., Munhall A., Johnson S.W. Synaptic plasticity in rat subthalamic nucleus induced by high-frequency stimulation. Synapse 2003, 50:314-319.
41. Siderowf A., Jaggi J.L., Xie S.X., Loveland-Jones C., Leng L., Hurtig H., Colcher A., Stern M., Chou K.L., Liang G., Maccarone H., Simuni T., Baltuch G. Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease. Mov. Disord. 2006, 21:746-753.
42. Smith K.A., Fairburn C.G., Cowen P.J. Relapse of depression after rapid depletion of tryptophan. Lancet 1997, 349:915-919.
43. Smith K.A., Morris J.S., Friston K.J., Cowen P.J., Dolan R.J. Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. Br. J. Psychiatry 1999, 174:525-529.
44. Steinbusch H.W. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 1981, 6:557-618.
45. Takeshita S., Kurisu K., Trop L., Arita K., Akimitsu T., Verhoeff N.P. Effect of subthalamic stimulation on mood state in Parkinson's disease: evaluation of previous facts and problems. Neurosurg. Rev. 2005, 28:179-186. discussion 187.
46. Tan S., Vlamings R., Lim L., Sesia T., Janssen M.L., Steinbusch H.W., Visser-Vandewalle V., Temel Y. Experimental deep brain stimulation in animal models. Neurosurgery 2010, 67:1073-1079. discussion1080.
47. Taylor M.J., Freemantle N., Geddes J.R., Bhagwagar Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch. Gen. Psychiatry 2006, 63:1217-1223.
48. Temel Y., Visser-Vandewalle V., Aendekerk B., Rutten B., Tan S., Scholtissen B., Schmitz C., Blokland A., Steinbusch H.W. Acute and separate modulation of motor and cognitive performance in parkinsonian rats by bilateral stimulation of the subthalamic nucleus. Exp. Neurol. 2005, 193:43-52.
49. Temel Y., Kessels A., Tan S., Topdag A., Boon P., Visser-Vandewalle V. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat. Disord. 2006, 12:265-272.
50. Temel Y., Visser-Vandewalle V., Kaplan S., Kozan R., Daemen M.A., Blokland A., Schmitz C., Steinbusch H.W. Protection of nigral cell death by bilateral subthalamic nucleus stimulation. Brain Res. 2006, 1120:100-105.
51. Temel Y., Boothman L.J., Blokland A., Magill P.J., Steinbusch H.W., Visser-Vandewalle V., Sharp T. Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17087-17092.
52. Temel Y., Wilbrink P., Duits A., Boon P., Tromp S., Ackermans L., van Kranen-Mastenbroek V., Weber W., Visser-Vandewalle V. Single electrode and multiple electrode guided electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. Neurosurgery 2007, 61:346-355. discussion 355-7.
53. Temperli P., Ghika J., Villemure J.G., Burkhard P.R., Bogousslavsky J., Vingerhoets F.J. How do parkinsonian signs return after discontinuation of subthalamic DBS?. Neurology 2003, 60:78-81.
54. Thobois S., Ardouin C., Lhommee E., Klinger H., Lagrange C., Xie J., Fraix V., Coelho Braga M.C., Hassani R., Kistner A., Juphard A., Seigneuret E., Chabardes S., Mertens P., Polo G., Reilhac A., Costes N., Lebars D., Savasta M., Tremblay L., Quesada J.L., Bosson J.L., Benabid A.L., Broussolle E., Pollak P., Krack P. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010, 133:1111-1127.
55. Tommasi G., Lanotte M., Albert U., Zibetti M., Castelli L., Maina G., Lopiano L. Transient acute depressive state induced by subthalamic region stimulation. J. Neurol. Sci. 2008, 273:135-138.
56. Troster A.I., Fields J.A., Wilkinson S., Pahwa R., Koller W.C., Lyons K.E. Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology. Stereotact. Funct. Neurosurg. 2003, 80:43-47.
57. van der Kooy D. The organization of the thalamic, nigral and raphe cells projecting to the medial vs lateral caudate-putamen in rat. A fluorescent retrograde double labeling study. Brain Res. 1979, 169:381-387.
58. van Praag H.M., de Haan S. Central serotonin metabolism and frequency of depression. Psychiatry Res. 1979, 1:219-224.
59. Visser-Vandewalle V., van der Linden C., Temel Y., Celik H., Ackermans L., Spincemaille G., Caemaert J. Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up study. Parkinsonism Relat. Disord. 2005, 11:157-165.
60. Vlamings R., Visser-Vandewalle V., Koopmans G., Joosten E.A., Kozan R., Kaplan S., Steinbusch H.W., Temel Y. High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats. Neuroscience 2007, 148:815-823.
61. Vlamings R., Visser-Vandewalle V., Kozan R., Kaplan S., Steinbusch H.W., Temel Y. Bilateral high frequency stimulation of the subthalamic nucleus normalizes COX activity in the substantia nigra of Parkinsonian rats. Brain Res. 2009, 1288:143-148.
62. Voon V., Krack P., Lang A.E., Lozano A.M., Dujardin K., Schupbach M., D'Ambrosia J., Thobois S., Tamma F., Herzog J., Speelman J.D., Samanta J., Kubu C., Rossignol H., Poon Y.Y., Saint-Cyr J.A., Ardouin C., Moro E. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008, 131:2720-2728.
63. Wallman M.J., Gagnon D., Parent M. Serotonin innervation of human basal ganglia. Eur. J. Neurosci. 2011, 33:1519-1532.
64. Weaver F.M., Follett K., Stern M., Hur K., Harris C., Marks W.J., Rothlind J., Sagher O., Reda D., Moy C.S., Pahwa R., Burchiel K., Hogarth P., Lai E.C., Duda J.E., Holloway K., Samii A., Horn S., Bronstein J., Stoner G., Heemskerk J., Huang G.D. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. Jama 2009, 301:63-73.
65. Williams A., Gill S., Varma T., Jenkinson C., Quinn N., Mitchell R., Scott R., Ives N., Rick C., Daniels J., Patel S., Wheatley K. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010, 9:581-591.